Senate advances $9 million in opioid-abatement spending; oversight, outcomes added

The Vermont Senate on April 24 advanced H.218, a bill consolidating appropriations from the opioid abatement special fund for prevention, treatment and recovery programs, and ordered it to a third reading after committee reports and floor questions about outcomes measurement and a numeric error.

Senator Lydia Lyons, the senator recognized for the report of the Committee on Health and Welfare, told colleagues that the bill is “mostly about the appropriation of money from the opioid abatement fund,” which stems from a settlement with the pharmaceutical industry. Lyons summarized that the bill contains continuing and one-time appropriations for a range of programs, including a preferred provider network for substance use disorder providers, contingency-management programs in the Department of Corrections, funding for wound-care training related to xylazine exposure, harm-reduction programs, youth prevention and treatment grants, recovery residences, and peer-support positions in rural areas.

Why it matters: lawmaker supporters said consolidating the appropriations into one bill makes oversight easier because the money comes from a dedicated special fund. Several senators urged stronger outcomes reporting so future appropriations can be data-informed.

Committee and fiscal details The Committee on Appropriations reported that the opioid abatement special fund began with “over $26,000,000” in 2023–24; last year about $14,000,000 was appropriated, leaving an unappropriated balance the committee described as roughly $12,000,000. The committee’s report said approximately $9,000,000 is contained in H.218 and that, based on current estimates, the fund can support the requested spending in the near term though the settlement receipts will decline over time.

Lyons and other committee members emphasized outcome tracking. The bill instructs recipients to collect and report outcome measures so that the opioid abatement advisory committee can make future, data-driven allocation decisions. Lyons said some appropriations in the bill are ongoing until the fund is exhausted; other items are one-time grants or pilot funding through 2028, including continued support for Burlington’s Opioid Protection Center pilot.

Floor questions and technical correction Senators on the floor asked about metrics for success, and the Senate’s representative on the opioid settlement committee explained the committee’s application, score and presentation process for awardees. A scrivener’s error was identified on page 4 of the bill: the judicial-branch training line was listed at an incorrect dollar amount. Senators noted the fiscal note indicates the correct figure is $50,000; the Senate said it will propose a corrective amendment the next day.

Next steps After floor discussion and a voice vote, the Senate ordered H.218 read a third time; members will consider a technical amendment tomorrow to correct the typographical dollar amount. The bill includes an effective date in some sections and specific ongoing appropriations and reporting requirements that supporters said will let the advisory committee base future awards on outcomes data.